The lab analyst applies an additional in situ hybridization single probe stain on a slide or slides prepared from the same patient specimen as the initial probe stain, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the stained slides, including manually counting or estimating the number and location of probes.
For clinical responsibility, terminology, tips and additional info
start codify free trial.